157 related articles for article (PubMed ID: 38709349)
1. Scopoletin alleviates high glucose-induced toxicity in human renal proximal tubular cells via inhibition of oxidative damage, epithelial-mesenchymal transition, and fibrogenesis.
Kundu S; Ghosh S; Sahu BD
Mol Biol Rep; 2024 May; 51(1):620. PubMed ID: 38709349
[TBL] [Abstract][Full Text] [Related]
2. Quercetin inhibits the mTORC1/p70S6K signaling-mediated renal tubular epithelial-mesenchymal transition and renal fibrosis in diabetic nephropathy.
Lu Q; Ji XJ; Zhou YX; Yao XQ; Liu YQ; Zhang F; Yin XX
Pharmacol Res; 2015 Sep; 99():237-47. PubMed ID: 26151815
[TBL] [Abstract][Full Text] [Related]
3. Astragaloside IV attenuates high glucose-induced EMT by inhibiting the TGF-β/Smad pathway in renal proximal tubular epithelial cells.
Wang YN; Zhao SL; Su YY; Feng JX; Wang S; Liao XM; Wang LN; Li JC; Meng P; Li HY; Zhang YF
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32515466
[TBL] [Abstract][Full Text] [Related]
4. Empagliflozin reduces high glucose-induced oxidative stress and miR-21-dependent TRAF3IP2 induction and RECK suppression, and inhibits human renal proximal tubular epithelial cell migration and epithelial-to-mesenchymal transition.
Das NA; Carpenter AJ; Belenchia A; Aroor AR; Noda M; Siebenlist U; Chandrasekar B; DeMarco VG
Cell Signal; 2020 Apr; 68():109506. PubMed ID: 31862399
[TBL] [Abstract][Full Text] [Related]
5. Chrysin inhibits diabetic renal tubulointerstitial fibrosis through blocking epithelial to mesenchymal transition.
Kang MK; Park SH; Choi YJ; Shin D; Kang YH
J Mol Med (Berl); 2015 Jul; 93(7):759-72. PubMed ID: 26062793
[TBL] [Abstract][Full Text] [Related]
6. NQO1 alleviates renal fibrosis by inhibiting the TLR4/NF-κB and TGF-β/Smad signaling pathways in diabetic nephropathy.
Qiu D; Song S; Chen N; Bian Y; Yuan C; Zhang W; Duan H; Shi Y
Cell Signal; 2023 Aug; 108():110712. PubMed ID: 37196773
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of TSC1 promotes epithelial-mesenchymal transition of renal tubular epithelial cells in mouse diabetic nephropathy.
Lu Q; Chen YB; Yang H; Wang WW; Li CC; Wang L; Wang J; Du L; Yin XX
Acta Pharmacol Sin; 2019 Dec; 40(12):1555-1567. PubMed ID: 31235817
[TBL] [Abstract][Full Text] [Related]
8. Beta-casomorphin-7 prevents epithelial-mesenchymal transdifferentiation of NRK-52E cells at high glucose level: Involvement of AngII-TGF-β1 pathway.
Zhang W; Song S; Liu F; Liu Y; Zhang Y
Peptides; 2015 Aug; 70():37-44. PubMed ID: 25882007
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin AT1 receptor activation mediates high glucose-induced epithelial-mesenchymal transition in renal proximal tubular cells.
Zhou L; Xue H; Yuan P; Ni J; Yu C; Huang Y; Lu LM
Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):e152-7. PubMed ID: 20590668
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of thioredoxin-interacting protein ameliorates high glucose-induced epithelial to mesenchymal transition in renal tubular epithelial cells.
Wei J; Shi Y; Hou Y; Ren Y; Du C; Zhang L; Li Y; Duan H
Cell Signal; 2013 Dec; 25(12):2788-96. PubMed ID: 24041652
[TBL] [Abstract][Full Text] [Related]
11. lncRNA MALAT1 mediated high glucose-induced HK-2 cell epithelial-to-mesenchymal transition and injury.
Zhang J; Jiang T; Liang X; Shu S; Xiang X; Zhang W; Guo T; Xie W; Deng W; Tang X
J Physiol Biochem; 2019 Nov; 75(4):443-452. PubMed ID: 31388927
[TBL] [Abstract][Full Text] [Related]
12. Membrane rafts-redox signalling pathway contributes to renal fibrosis via modulation of the renal tubular epithelial-mesenchymal transition.
Han WQ; Xu L; Tang XF; Chen WD; Wu YJ; Gao PJ
J Physiol; 2018 Aug; 596(16):3603-3616. PubMed ID: 29863758
[TBL] [Abstract][Full Text] [Related]
13. Troglitazone ameliorates high glucose-induced EMT and dysfunction of SGLTs through PI3K/Akt, GSK-3β, Snail1, and β-catenin in renal proximal tubule cells.
Lee YJ; Han HJ
Am J Physiol Renal Physiol; 2010 May; 298(5):F1263-75. PubMed ID: 20015942
[TBL] [Abstract][Full Text] [Related]
14. Nudel involvement in the high-glucose-induced epithelial-mesenchymal transition of tubular epithelial cells.
Zhang W; Xing L; Xu L; Jin X; Du Y; Feng X; Liu S; Liu Q
Am J Physiol Renal Physiol; 2019 Jan; 316(1):F186-F194. PubMed ID: 30539652
[TBL] [Abstract][Full Text] [Related]
15. Pirfenidone suppresses MAPK signalling pathway to reverse epithelial-mesenchymal transition and renal fibrosis.
Li Z; Liu X; Wang B; Nie Y; Wen J; Wang Q; Gu C
Nephrology (Carlton); 2017 Aug; 22(8):589-597. PubMed ID: 27245114
[TBL] [Abstract][Full Text] [Related]
16. The role of the p38 MAPK signaling pathway in high glucose-induced epithelial-mesenchymal transition of cultured human renal tubular epithelial cells.
Lv ZM; Wang Q; Wan Q; Lin JG; Hu MS; Liu YX; Wang R
PLoS One; 2011; 6(7):e22806. PubMed ID: 21829520
[TBL] [Abstract][Full Text] [Related]
17. A bioinformatics and network pharmacology approach to the mechanisms of action of Shenxiao decoction for the treatment of diabetic nephropathy.
Mou X; Zhou DY; Zhou D; Liu K; Chen LJ; Liu WH
Phytomedicine; 2020 Apr; 69():153192. PubMed ID: 32200292
[TBL] [Abstract][Full Text] [Related]
18. Micro-vesicles from mesenchymal stem cells over-expressing miR-34a inhibit transforming growth factor-β1-induced epithelial-mesenchymal transition in renal tubular epithelial cells in vitro.
He J; Jiang YL; Wang Y; Tian XJ; Sun SR
Chin Med J (Engl); 2020 Apr; 133(7):800-807. PubMed ID: 32149762
[TBL] [Abstract][Full Text] [Related]
19. miR-133b and miR-199b knockdown attenuate TGF-β1-induced epithelial to mesenchymal transition and renal fibrosis by targeting SIRT1 in diabetic nephropathy.
Sun Z; Ma Y; Chen F; Wang S; Chen B; Shi J
Eur J Pharmacol; 2018 Oct; 837():96-104. PubMed ID: 30125566
[TBL] [Abstract][Full Text] [Related]
20. De-Glycyrrhizinated Licorice Extract Attenuates High Glucose-Stimulated Renal Tubular Epithelial-Mesenchymal Transition via Suppressing the Notch2 Signaling Pathway.
Hsu YC; Chang PJ; Tung CW; Shih YH; Ni WC; Li YC; Uto T; Shoyama Y; Ho C; Lin CL
Cells; 2020 Jan; 9(1):. PubMed ID: 31948095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
